A number of FDA-approved AI applications in prostate cancer imaging, detection, and classification implemented in clinical practice include ProstatID (Version 2.0), Quantib Prostate (Version 3.0), and PROView (Version 1.0) using MRI images and aPROMISE (Version 1.0) using PSMA PET/CT images [10]. The gene discussed is FOLH1; the disease is Familial prostate cancer.